Toll Free: 1-888-928-9744

Global Urological Cancer Drugs Market Size, Status and Forecast 2025

Published: Feb, 2018 | Pages: 101 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report studies the global Urological Cancer Drugs market, analyzes and researches the Urological Cancer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Novartis
    Pfizer
    Johnson & Johnson
    AstraZeneca
    Astellas
    Bristol-Myers Squibb
    Abbott Laboratories
    Celgene Corporation
    Dendreon Corporation
    Ferring Pharmaceuticals
    GlaxoSmithKline
    Indevus Pharmaceuticals Inc
    Ipsen
    Roche Healthcare
    Sanofi S.A
    Tolmar Inc

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Tablets
    Injection

Market segment by Application, Urological Cancer Drugs can be split into
    Prostate Cancer
    Bladder Cancer
    Kidney Cancer
    Testicular Cancer
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.


 Table of Contents

Global Urological Cancer Drugs Market Size, Status and Forecast 2025
1 Industry Overview of Urological Cancer Drugs
    1.1  Urological Cancer Drugs Market Overview
        1.1.1 Urological Cancer Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Urological Cancer Drugs Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Urological Cancer Drugs Market by Type
        1.3.1 Tablets
        1.3.2 Injection
    1.4 Urological Cancer Drugs Market by End Users/Application
        1.4.1 Prostate Cancer
        1.4.2 Bladder Cancer
        1.4.3 Kidney Cancer
        1.4.4 Testicular Cancer
        1.4.5 Other

2 Global Urological Cancer Drugs Competition Analysis by Players
    2.1 Urological Cancer Drugs Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Novartis
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.1.5 Recent Developments
    3.2 Pfizer
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.2.5 Recent Developments
    3.3 Johnson & Johnson
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.3.5 Recent Developments
    3.4 AstraZeneca
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.4.5 Recent Developments
    3.5 Astellas
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.5.5 Recent Developments
    3.6 Bristol-Myers Squibb
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.6.5 Recent Developments
    3.7 Abbott Laboratories
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.7.5 Recent Developments
    3.8 Celgene Corporation
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.8.5 Recent Developments
    3.9 Dendreon Corporation
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.9.5 Recent Developments
    3.10 Ferring Pharmaceuticals
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Urological Cancer Drugs Revenue (Million USD) (2013-2018)
        3.10.5 Recent Developments
    3.11 GlaxoSmithKline
    3.12 Indevus Pharmaceuticals Inc
    3.13 Ipsen
    3.14 Roche Healthcare
    3.15 Sanofi S.A
    3.16 Tolmar Inc

4 Global Urological Cancer Drugs Market Size by Type and Application (2013-2018)
    4.1 Global Urological Cancer Drugs Market Size by Type (2013-2018)
    4.2 Global Urological Cancer Drugs Market Size by Application (2013-2018)
    4.3 Potential Application of Urological Cancer Drugs in Future
    4.4 Top Consumer/End Users of Urological Cancer Drugs

5 United States Urological Cancer Drugs Development Status and Outlook
    5.1 United States Urological Cancer Drugs Market Size (2013-2018)
    5.2 United States Urological Cancer Drugs Market Size and Market Share by Players (2013-2018)
    5.3 United States Urological Cancer Drugs Market Size by Application (2013-2018)

6 EU Urological Cancer Drugs Development Status and Outlook
    6.1 EU Urological Cancer Drugs Market Size (2013-2018)
    6.2 EU Urological Cancer Drugs Market Size and Market Share by Players (2013-2018)
    6.3 EU Urological Cancer Drugs Market Size by Application (2013-2018)

7 Japan Urological Cancer Drugs Development Status and Outlook
    7.1 Japan Urological Cancer Drugs Market Size (2013-2018)
    7.2 Japan Urological Cancer Drugs Market Size and Market Share by Players (2013-2018)
    7.3 Japan Urological Cancer Drugs Market Size by Application (2013-2018)

8 China Urological Cancer Drugs Development Status and Outlook
    8.1 China Urological Cancer Drugs Market Size (2013-2018)
    8.2 China Urological Cancer Drugs Market Size and Market Share by Players (2013-2018)
    8.3 China Urological Cancer Drugs Market Size by Application (2013-2018)

9 India Urological Cancer Drugs Development Status and Outlook
    9.1 India Urological Cancer Drugs Market Size (2013-2018)
    9.2 India Urological Cancer Drugs Market Size and Market Share by Players (2013-2018)
    9.3 India Urological Cancer Drugs Market Size by Application (2013-2018)

10 Southeast Asia Urological Cancer Drugs Development Status and Outlook
    10.1 Southeast Asia Urological Cancer Drugs Market Size (2013-2018)
    10.2 Southeast Asia Urological Cancer Drugs Market Size and Market Share by Players (2013-2018)
    10.3 Southeast Asia Urological Cancer Drugs Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Urological Cancer Drugs Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Urological Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.2 EU Urological Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.3 Japan Urological Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.4 China Urological Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.5 India Urological Cancer Drugs Revenue and Growth Rate (2018-2025)
        11.1.6 Southeast Asia Urological Cancer Drugs Revenue and Growth Rate (2018-2025)
    11.2 Global Urological Cancer Drugs Market Size (Value) by Type (2018-2025)
    11.3 Global Urological Cancer Drugs Market Size by Application (2018-2025)

12 Urological Cancer Drugs Market Dynamics
    12.1 Urological Cancer Drugs Market Opportunities
    12.2 Urological Cancer Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Urological Cancer Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Urological Cancer Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Global Urological Cancer Drugs Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Urological Cancer Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Urological Cancer Drugs Market Share by Regions (2013-2018)
    Figure United States Urological Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure EU Urological Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Urological Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Urological Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Urological Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Urological Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Urological Cancer Drugs Revenue Market Share by Type in 2017
    Figure Tablets Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Injection Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Urological Cancer Drugs Market Share by Application in 2017
    Figure Urological Cancer Drugs Market Size (Million USD) and Growth Rate in Prostate Cancer (2013-2018)
    Figure Urological Cancer Drugs Market Size (Million USD) and Growth Rate in Bladder Cancer (2013-2018)
    Figure Urological Cancer Drugs Market Size (Million USD) and Growth Rate in Kidney Cancer (2013-2018)
    Figure Urological Cancer Drugs Market Size (Million USD) and Growth Rate in Testicular Cancer (2013-2018)
    Figure Urological Cancer Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
    Table Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Urological Cancer Drugs Market Size Share by Players in 2013
    Figure Urological Cancer Drugs Market Size Share by Players in 2017
    Table Novartis Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Novartis (2013-2018)
    Figure Novartis Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Pfizer Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
    Figure Pfizer Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Johnson & Johnson Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Johnson & Johnson (2013-2018)
    Figure Johnson & Johnson Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table AstraZeneca Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
    Figure AstraZeneca Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Astellas Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Astellas (2013-2018)
    Figure Astellas Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Bristol-Myers Squibb Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
    Figure Bristol-Myers Squibb Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Abbott Laboratories Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Abbott Laboratories (2013-2018)
    Figure Abbott Laboratories Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Celgene Corporation Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Celgene Corporation (2013-2018)
    Figure Celgene Corporation Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Dendreon Corporation Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Dendreon Corporation (2013-2018)
    Figure Dendreon Corporation Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Ferring Pharmaceuticals Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Ferring Pharmaceuticals (2013-2018)
    Figure Ferring Pharmaceuticals Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table GlaxoSmithKline Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of GlaxoSmithKline (2013-2018)
    Figure GlaxoSmithKline Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Indevus Pharmaceuticals Inc Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Indevus Pharmaceuticals Inc (2013-2018)
    Figure Indevus Pharmaceuticals Inc Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Ipsen Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Ipsen (2013-2018)
    Figure Ipsen Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Roche Healthcare Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Roche Healthcare (2013-2018)
    Figure Roche Healthcare Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Sanofi S.A Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Sanofi S.A (2013-2018)
    Figure Sanofi S.A Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Tolmar Inc Basic Information List
    Table Urological Cancer Drugs Business Revenue (Million USD) of Tolmar Inc (2013-2018)
    Figure Tolmar Inc Urological Cancer Drugs Business Revenue Market Share (2013-2018)
    Table Global Urological Cancer Drugs Market Size (Million USD) by Product (2013-2018)
    Figure Global Urological Cancer Drugs Revenue Market Share (%) by Product (2013-2018)
    Figure Global Urological Cancer Drugs Market Share by Product in 2017
    Table Global Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure Global Urological Cancer Drugs Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Urological Cancer Drugs
    Figure United States Urological Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure United States Urological Cancer Drugs Market Size Share by Players in 2013
    Figure United States Urological Cancer Drugs Market Size Share by Players in 2017
    Table United States Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure United States Urological Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure United States Urological Cancer Drugs Market Size Share by Application in 2017
    Figure EU Urological Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table EU Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure EU Urological Cancer Drugs Market Size Share by Players in 2013
    Figure EU Urological Cancer Drugs Market Size Share by Players in 2017
    Table EU Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure EU Urological Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure EU Urological Cancer Drugs Market Size Share by Application in 2017
    Figure Japan Urological Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Japan Urological Cancer Drugs Market Size Share by Players in 2013
    Figure Japan Urological Cancer Drugs Market Size Share by Players in 2017
    Table Japan Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure Japan Urological Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Urological Cancer Drugs Market Size Share by Application in 2017
    Figure China Urological Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure China Urological Cancer Drugs Market Size Share by Players in 2013
    Figure China Urological Cancer Drugs Market Size Share by Players in 2017
    Table China Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure China Urological Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure China Urological Cancer Drugs Market Size Share by Application in 2017
    Figure India Urological Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure India Urological Cancer Drugs Market Size Share by Players in 2013
    Figure India Urological Cancer Drugs Market Size Share by Players in 2017
    Table India Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure India Urological Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure India Urological Cancer Drugs Market Size Share by Application in 2017
    Figure Southeast Asia Urological Cancer Drugs Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Urological Cancer Drugs Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Urological Cancer Drugs Market Size Share by Players in 2013
    Figure Southeast Asia Urological Cancer Drugs Market Size Share by Players in 2017
    Table Southeast Asia Urological Cancer Drugs Market Size by Application (2013-2018)
    Figure Southeast Asia Urological Cancer Drugs Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Urological Cancer Drugs Market Size Share by Application in 2017
    Figure Global Urological Cancer Drugs Market Size and Growth Rate (2018-2025)
    Table Global Urological Cancer Drugs Market Size (Million USD) by Regions (2018-2025)
    Figure Global Urological Cancer Drugs Market Size Share (2018-2025)
    Figure Global Urological Cancer Drugs Market Size Share by Regions in 2025
    Figure United States Urological Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure EU Urological Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Urological Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Urological Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Urological Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Urological Cancer Drugs Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Urological Cancer Drugs Market Size (Million USD) by Type (2018-2025)
    Figure Global Urological Cancer Drugs Market Size Share by Type in 2018
    Figure Global Urological Cancer Drugs Market Size Share by Type in 2025
    Table Global Urological Cancer Drugs Market Size (Million USD) by Application (2018-2025)
    Figure Global Urological Cancer Drugs Market Size (Million USD) by Application in 2018
    Figure Global Urological Cancer Drugs Market Size (Million USD) by Application in 2025
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3300
Multi User - US $6600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify